Please login to the form below

Not currently logged in
Email:
Password:

Richard Vellacott joins Horizon Discovery as chief financial officer

His 15 years’ industry includes time in Deloitte’s life sciences practice

Cambridge, UK-based personalised medicine research tool firm Horizon Discovery has appointed Richard Vellacott as chief financial officer.

He was most recently vice president, finance at hi-tech company CSR, but joins Horizon with over 15 years' experience in working with life science companies.

During this time Vellacott served as a director in Deloitte's life sciences practice, where he specialised in capital market transactions including IPOs, M&A and fundraising on both the UK and the US markets.

Horizon's CEO Dr Darrin Disley said: “I'm delighted to welcome Richard to Horizon. As the company continues to expand, it is essential that we maintain a highly experienced executive team with the skills to deliver our growth objectives. Richard's background is an ideal fit and I very much look forward to working with him.”

8th August 2012

Share

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Syneos Health®

Syneos Health® (Nasdaq:SYNH) is the only fully integrated biopharmaceutical solutions organization. The Company, including a Contract Research Organization (CRO) and...

Latest intelligence

Good design saves lives
Good design and creative thinking are essential if we are to improve on existing problems in new ways, which is why design and creativity within healthcare is vital. Health is...
Why you must understand the pricing of patient recruitment companies
Recruiting a diverse range of patients and engaging with them for your clinical trial isn’t an easy task, which means you might turn to patient recruitment companies, like us, who...
wearable health tech
A cultural shift in clinical research
Research organisations across the board are experimenting with new technologies...

Infographics